Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.
Silvestris N, Scartozzi M, Graziano G, Santini D, Lorusso V, Maiello E, Barni S, Cinieri S, Loupakis F, Pisconti S, Brunetti AE, Palasciano G, Palmieri VO, Del Prete M, Dell'Aquila E, Latiano TP, Petrelli F, Lutrino S, Rossini D, Giampieri R, Lotesoriere C, Cascinu S. Silvestris N, et al. Among authors: del prete m. Expert Opin Biol Ther. 2015 Feb;15(2):155-62. doi: 10.1517/14712598.2015.986452. Epub 2014 Nov 19. Expert Opin Biol Ther. 2015. PMID: 25411089
5-Fluorouracil pharmacogenomics: still rocking after all these years?
Scartozzi M, Maccaroni E, Giampieri R, Pistelli M, Bittoni A, Del Prete M, Berardi R, Cascinu S. Scartozzi M, et al. Among authors: del prete m. Pharmacogenomics. 2011 Feb;12(2):251-65. doi: 10.2217/pgs.10.167. Pharmacogenomics. 2011. PMID: 21332317 Review.
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients.
Scartozzi M, Loretelli C, Berardi R, Pierantoni C, Silva RR, Mari D, Giampieri R, Faloppi L, Pistelli M, Maccaroni E, Bittoni A, Del Prete M, Galizia E, Cascinu S. Scartozzi M, et al. Among authors: del prete m. Dig Liver Dis. 2012 Jan;44(1):74-9. doi: 10.1016/j.dld.2011.08.006. Epub 2011 Sep 3. Dig Liver Dis. 2012. PMID: 21893437 Clinical Trial.
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab.
Scartozzi M, Giampieri R, Maccaroni E, Mandolesi A, Biagetti S, Alfonsi S, Giustini L, Loretelli C, Faloppi L, Bittoni A, Bianconi M, Del Prete M, Bearzi I, Cascinu S. Scartozzi M, et al. Among authors: del prete m. J Transl Med. 2012 Apr 10;10:71. doi: 10.1186/1479-5876-10-71. J Transl Med. 2012. PMID: 22490361 Free PMC article.
Angiogenetic pathway as a therapeutic target in renal cell carcinoma.
Bianconi M, Scartozzi M, Faloppi L, Bittoni A, Maccaroni E, Giampieri R, Del Prete M, Burattini L, Cascinu S. Bianconi M, et al. Among authors: del prete m. Anal Quant Cytol Histol. 2012 Feb;34(1):15-22. Anal Quant Cytol Histol. 2012. PMID: 22590815 Review.
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.
Scartozzi M, Loretelli C, Galizia E, Mandolesi A, Pistelli M, Bittoni A, Giampieri R, Faloppi L, Bianconi M, Del Prete M, Bianchi F, Belvederesi L, Bearzi I, Cascinu S. Scartozzi M, et al. Among authors: del prete m. PLoS One. 2012;7(7):e38192. doi: 10.1371/journal.pone.0038192. Epub 2012 Jul 9. PLoS One. 2012. PMID: 22808003 Free PMC article.
153 results